The study will evaluate the combination of NEO-PV-01 with nivolumab (anti-PD-1 therapy) in metastatic or advanced melanoma patients Neon Therapeutics Inc., an immuno-oncology company which develops neoantigen-based treatments has reportedly presented updated data that describes pathologic and immune markers related with durable clinical advantages in …
Avatera Medical has been developing robots to help surgeons in carrying out minimally invasive operations. Avatera Medical, a German medical devices manufacturer, is considering a stock market flotation as it intends to gain proceeds to finance expansion, cited sources close to the matter. The company …
The heart monitoring and ECG functions of the device have been CE marked, making them compliant with European Union standards for health and safety in medical devices Apple has reportedly confirmed the official launch of life-saving health features for the first time to UK users …
The approval resulted from reviewing the data from the phase 3 ‘DEPICT’ clinical programme and also a dedicated trial in patients in Japan AstraZeneca recently announced that Forxiga (dapagliflozin) as an oral supplement treatment to insulin for adults having type-1 diabetes has won approval from …
The clinical data would be coming from the company’s phase-2 ampreloxetine clinical trials. The 20-week-long data supports a previously announced medical observation after approximately four weeks of therapy. Theravance Biopharma, Inc., (Theravance Biopharma), a renowned diversified biopharmaceutical company, has reportedly announced the outcome of the …
Forxiga is the first oral supplement approved in Europe as an adjunct for Type-1 diabetes patients. AstraZeneca has announced that European Commission (EC) has approved its Forxiga tablets for use in Type-1 diabetes as an oral supplement to insulin in adults. Patients with Type-1 diabetes …
The latest multi-channel consumer campaign is likely to feature several QBREXZA patients Dermira Inc., a US-based biopharmaceutical company, is currently in the news for introducing a brand-new direct-to-consumer campaign known as ‘Life Unfolds’, which has been strategized to spread awareness of QBREXZA™ treatment. As per …
Roche has alleged that medical supply companies caused it to pay $87 million and that it also lost similar amount of sales Roche has sued executives of a Utah-based company claiming that it lost millions due to a fraud involving diabetes test strips. Roche has …
Zulresso will be provided through a restricted program in which a healthcare expert administers the drug in an authorized health facility Reports confirm that the U.S. Food and Drug Administration has recently approved Zulresso injection for the treatment of Post-Partum depression (PPD) in adult women. …